Skip to main content

Table 1 Baseline characteristics and conventional atherothrombotic risk factors of the study groups

From: Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects

  Overweight subjects Normal weight subjects with CHD Controls
No. of subjects 275 337 103
BMI, kg/m2 29.67 ± 2.56*** 23.85 ± 2.01 23.92 ± 1.88
Age, yr 61.36 ± 10.39 62.01 ± 11.18 61.95 ± 14.79
Male gender, n (%) 211 (76.7%) 251 (74.4%) 74 (71.8%)
Diabetes mellitus, n (%) 107 (38.9%)*** 168 (49.8%)*** 6 (5.8%)
Hypertension, n (%) 173 (62.9)** 184 (54.6%) 49 (47.5%)
Smokers, n (%) 32 (11.6%) 68 (20.2%)** 7 (6.8%)
Hypercholesterolemia, n (%) 121 (44%)** 115 (34.1%) 30 (29.1%)
Lp(a) (mg/dl) 16.2 (4–43) 19.6 (5.2–49) 14.9 (4.3–45.3)
  1. BMI, body mass index; CHD, coronary heart disease; Lp(a), lipoprotein(a). Lp(a) levels are expressed as medians (interquartile range within brackets). **P < 0.01 ***P < 0.001, versus controls.